Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Zastrozhin, Mikhail
37  Ergebnisse:
Personensuche X
?
1

Meta-analysis of pharmacogenetic clinical decision support ..:

Skryabin, Valentin ; Rozochkin, Ilya ; Zastrozhin, Mikhail...
The Pharmacogenomics Journal.  23 (2022)  2-3 - p. 45-49 , 2022
Link: https://doi.org/10.1038/..
 
?
2

Effects of CYP2D6*4 polymorphism on the steady-state concen..:

Zastrozhin, Mikhail ; Skryabin, Valentin ; Petukhov, Aleksey...
Journal of Psychopharmacology.  36 (2022)  10 - p. 1146-1150 , 2022
Link: https://doi.org/10.1177/..
 
?
3

Effects of CYP2C19*17 Genetic Polymorphisms on the Steady-S..:

Skryabin, Valentin Yurievich ; Zastrozhin, Mikhail ; Torrado, Marco...
Hospital Pharmacy.  56 (2020)  5 - p. 592-596 , 2020
Link: https://doi.org/10.1177/..
 
?
4

M77 USING A PERSONALIZED CLINICAL DECISION SUPPORT SYSTEM F..:

Zastrozhin, Mikhail ; Sychev, Dmitry ; Bryun, Eugeniy
European Neuropsychopharmacology.  29 (2019)  - p. S208-S209 , 2019
Link: https://doi.org/10.1016/..
 
?
5

Investigating the Use of Pharmacogenetic and Pharmacometabo..:

Skryabin, Valentin Yurievich ; Zastrozhin, Mikhail Sergeevich ; Parkhomenko, Aleksandra Aleksandrovna...
Hospital Pharmacy.  58 (2023)  4 - p. 363-367 , 2023
Link: https://doi.org/10.1177/..
 
?
6

Time trends in tuberculosis mortality across the BRICS: an ..:

Zou, Zhiyong ; Liu, Guangqi ; Hay, Simon I....
eClinicalMedicine.  53 (2022)  - p. 101646 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Using the CYP3A Activity Evaluation to Predict the Efficacy..:

Skryabin, Valentin Yu. ; Zastrozhin, Mikhail S. ; Grishina, Elena A....
Journal of Pharmacy Practice.  35 (2021)  4 - p. 518-523 , 2021
Link: https://doi.org/10.1177/..
 
?
8

The Effect of Cyp2d6 Gene Polymorphism on the Efficacy and ..:

Zastrozhin, Mikhail S. ; Smirnov, Valery V. ; Sorokin, Alexander S....
Annals of the Russian academy of medical sciences.  74 (2019)  3 - p. 185-191 , 2019
Link: https://doi.org/10.15690..
 
?
9

Effects of CYP2D6 genetic polymorphisms on the efficacy and..:

Zastrozhin, Mikhail S ; Grishina, Elena A ; Denisenko, Nataliya P...
Pharmacogenomics and Personalized Medicine.  11 (2018)  - p. 113-119 , 2018
Link: https://doi.org/10.2147/..
 
?
10

Influence of CYP3A Activity on the Efficacy and Safety of F..:

Zastrozhin, Mikhail S. ; Smirnov, Valery V. ; Sorokin, Alexander S....
Annals of the Russian academy of medical sciences.  73 (2018)  6 - p. 411-419 , 2018
Link: https://doi.org/10.15690..
 
?
11

The influence of CYP3A5 polymorphisms on haloperidol treatm..:

Zastrozhin, Mikhail Sergeevich ; Grishina, Elena ; Ryzhikova, Kristina Anatolievna...
Pharmacogenomics and Personalized Medicine.  11 (2017)  - p. 1-5 , 2017
Link: https://doi.org/10.2147/..
 
?
12

Pharmacogenetic evaluation of adverse events' risk in patie..:

Ivashchenko, Dmitriy V. ; Ryzhykova, Kristina A. ; Sozaeva, Zhannet A....
World Journal of Personalized Medicine.  1 (2017)  1 - p. 18-26 , 2017
Link: https://doi.org/10.14341..
 
?
13

Pharmacodynamic gene polymorphism and adverse drug reaction..:

Zastrozhin, Mikhail S. ; Sychev, Dmitry A. ; Grishina, Elena A...
World Journal of Personalized Medicine.  1 (2017)  1 - p. 5-12 , 2017
Link: https://doi.org/10.14341..
 
?
14

Global burden of peripheral artery disease and its risk fac..:

Kim, Min Seo ; Hwang, Jimin ; Yon, Dong Keon...
https://linkinghub.elsevier.com/retrieve/pii/S2214109X23003558.  , 2023
Link: https://doi.org/10.1016/..
 
?
15

Global burden of chronic respiratory diseases and risk fact..:

Momtazmanesh, Sara ; Moghaddam, Sahar Saeedi ; Ghamari, Seyyed-Hadi...
Journal: eClinicalMedicine.  , 2023
Link: http://hdl.handle.net/10..
 
1-15